|
1
|
Falank C, Fairfield H and Reagan MR:
Signaling interplay between bone marrow adipose tissue and multiple
myeloma cells. Front Endocrinol (Lausanne). 7(Suppl): 672016.
|
|
2
|
Palumbo A and Anderson K: Multiple
myeloma. N Engl J Med. 364:1046–1060. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zweegman S, Palumbo A, Bringhen S and
Sonneveld P: Age and aging in blood disorders: Multiple myeloma.
Haematologica. 99:1133–1137. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
American Cancer Society: Cancer Facts and
Figures 2017. American Cancer Society; Atlanta, GA: 2017,
https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2017.html.
|
|
5
|
Scheideler M, Elabd C, Zaragosi LE,
Chiellini C, Hackl H, Sanchez-Cabo F, Yadav S, Duszka K, Friedl G,
Papak C, et al: Comparative transcriptomics of human multipotent
stem cells during adipogenesis and osteoblastogenesis. BMC
Genomics. 9:3402008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mahindra A, Hideshima T and Anderson KC:
Multiple myeloma: Biology of the disease. Blood Rev. 24(Suppl 1):
S5–S11. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Podar K, Chauhan D and Anderson KC: Bone
marrow microenvironment and the identification of new targets for
myeloma therapy. Leukemia. 23:10–24. 2009. View Article : Google Scholar
|
|
8
|
Hideshima T, Bergsagel PL, Kuehl WM and
Anderson KC: Advances in biology of multiple myeloma: Clinical
applications. Blood. 104:607–618. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu J and Li Q: Review of the in vivo
functions of the p160 steroid receptor coactivator family. Mol
Endocrinol. 17:1681–1692. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Manier S, Sacco A, Leleu X, Ghobrial IM
and Roccaro AM: Bone marrow microenvironment in multiple myeloma
progression. J Biomed Biotechnol. 2012:1574962012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
York B, Yu C, Sagen JV, Liu Z, Nikolai BC,
Wu RC, Finegold M, Xu J and O'Malley BW: Reprogramming the
posttranslational code of SRC-3 confers a switch in mammalian
systems biology. Proc Natl Acad Sci USA. 107:11122–11127. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yan J, Tsai SY and Tsai MJ: SRC-3/AIB1:
Transcriptional coactivator in oncogenesis. Acta Pharmacol Sin.
27:387–394. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jin J, Wang Y, Wang J, Xu Y, Chen S, Wang
J, Ran X and Su Y: Increased radiosensitivity and radiation-induced
apoptosis in SRC-3 knockout mice. J Radiat Res. 55:443–450. 2014.
View Article : Google Scholar :
|
|
14
|
Jin J, Wang Y, Wang J, Xu Y, Chen SL, Wang
JP and Su YP: Impaired hematopoiesis and delayed thrombopoietic
recovery following sublethal irradiation in SRC-3 knockout mice.
Mol Med Rep. 9:1629–1633. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Warn-Cramer BJ, Cottrell GT, Burt JM and
Lau AF: Regulation of connexin-43 gap junctional intercellular
communication by mitogen-activated protein kinase. J Biol Chem.
273:9188–9196. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nimlamool W, Andrews RMK and Falk MM:
Connexin43 phosphorylation by PKC and MAPK signals VEGF-mediated
gap junction internalization. Mol Biol Cell. 26:2755–2768. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shishido SN, Delahaye A, Beck A and Nguyen
TA: The anticancer effect of PQ1 in the MMTV-PyVT mouse model. Int
J Cancer. 134:1474–1483. 2014. View Article : Google Scholar :
|
|
18
|
Kanczuga-Koda L, Sulkowska M, Koda M,
Rutkowski R and Sulkowski S: Increased expression of gap junction
protein -connexin 32 in lymph node metastases of human ductal
breast cancer. Folia Histochem Cytobiol. 45(Suppl 1): S175–S180.
2007.
|
|
19
|
Kanczuga-Koda L, Sulkowski S, Tomaszewski
J, Koda M, Sulkowska M, Przystupa W, Golaszewska J and Baltaziak M:
Connexins 26 and 43 correlate with Bak, but not with Bcl-2 protein
in breast cancer. Oncol Rep. 14:325–329. 2005.PubMed/NCBI
|
|
20
|
Zhou Y, Miao J, Wu H, Tang H, Kuang J,
Zhou X, Peng Y, Hu D, Shi D, Deng W, et al: PD-1 and PD-L1
expression in 132 recurrent nasopharyngeal carcinoma: The
correlation with anemia and outcomes. Oncotarget. 8:51210–51223.
2017.PubMed/NCBI
|
|
21
|
Morsing M, Klitgaard MC, Jafari A,
Villadsen R, Kassem M, Petersen OW and Rønnov-Jessen L: Evidence of
two distinct functionally specialized fibroblast lineages in breast
stroma. Breast Cancer Res. 18:1082016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang X, Sun Y, Wang Z, Huang Z, Li B and
Fu J: Up-regulation of connexin-43 expression in bone marrow
mesenchymal stem cells plays a crucial role in adhesion and
migration of multiple myeloma cells. Leuk Lymphoma. 56:211–218.
2015. View Article : Google Scholar
|
|
23
|
Basak GW, Srivastava AS, Malhotra R and
Carrier E: Multiple myeloma bone marrow niche. Curr Pharm
Biotechnol. 10:345–346. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shen X, Guo Y, Yu J, Qi J, Shi W, Wu X, Ni
H and Ju S: miRNA-202 in bone marrow stromal cells affects the
growth and adhesion of multiple myeloma cells by regulating B
cell-activating factor. Clin Exp Med. 16:307–316. 2016. View Article : Google Scholar
|
|
25
|
Khorasanizadeh M, Eskian M, Gelfand EW and
Rezaei N: Mitogen-activated protein kinases as therapeutic targets
for asthma. Pharmacol Ther. 174:112–126. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mugami S, Dobkin-Bekman M, Rahamim-Ben
Navi L and Naor Z: Differential roles of PKC isoforms (PKCs) in
GnRH stimulation of MAPK phosphorylation in gonadotrope derived
cells. Mol Cell Endocrinol. Apr 6–2017.Epub ahead of print.
PubMed/NCBI
|
|
27
|
Segalés J, Perdiguero E and Muñoz-Cánoves
P: Regulation of muscle stem cell functions: A focus on the p38
MAPK signaling pathway. Front Cell Dev Biol. 4:912016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ai XL, Chi Q, Qiu Y, Li HY, Li DJ, Wang JX
and Wang ZY: Gap junction protein connexin43 deregulation
contributes to bladder carcinogenesis via targeting MAPK pathway.
Mol Cell Biochem. 428:109–118. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Losa D, Köhler T, Bellec J, Dudez T,
Crespin S, Bacchetta M, Boulanger P, Hong SS, Morel S, Nguyen TH,
et al: Pseudomonas aeruginosa-induced apoptosis in airway
epithelial cells is mediated by gap junctional communication in a
JNK-dependent manner. J Immunol. 192:4804–4812. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shishido SN and Nguyen TA: Induction of
apoptosis by PQ1 a gap junction enhancer that upregulates connexin
43 and activates the MAPK signaling pathway in mammary carcinoma
cells. Int J Mol Sci. 17:1782016. View Article : Google Scholar
|
|
31
|
Geiger PC, Wright DC, Han DH and Holloszy
JO: Activation of p38 MAP kinase enhances sensitivity of muscle
glucose transport to insulin. Am J Physiol Endocrinol Metab.
288:E782–E788. 2005. View Article : Google Scholar
|
|
32
|
Uchiyama H, Barut BA, Mohrbacher AF,
Chauhan D and Anderson KC: Adhesion of human myeloma-derived cell
lines to bone marrow stromal cells stimulates interleukin-6
secretion. Blood. 82:3712–3720. 1993.PubMed/NCBI
|
|
33
|
Hideshima T, Mitsiades C, Tonon G,
Richardson PG and Anderson KC: Understanding multiple myeloma
pathogenesis in the bone marrow to identify new therapeutic
targets. Nat Rev Cancer. 7:585–598. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kumar S, Witzig TE, Timm M, Haug J, Wellik
L, Fonseca R, Greipp PR and Rajkumar SV: Expression of VEGF and its
receptors by myeloma cells. Leukemia. 17:2025–2031. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nefedova Y, Cheng P, Alsina M, Dalton WS
and Gabrilovich DI: Involvement of Notch-1 signaling in bone marrow
stroma-mediated de novo drug resistance of myeloma and other
malignant lymphoid cell lines. Blood. 103:3503–3510. 2004.
View Article : Google Scholar
|
|
36
|
Mori Y, Shimizu N, Dallas M, Niewolna M,
Story B, Williams PJ, Mundy GR and Yoneda T: Anti-alpha4 integrin
antibody suppresses the development of multiple myeloma and
associated osteoclastic osteolysis. Blood. 104:2149–2154. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Fu J: Cx43 expressed on bone marrow
stromal cells plays an essential role in multiple myeloma cell
survival and drug resistance. Arch Med Sci. 13:236–245. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Koul HK, Pal M and Koul S: Role of p38 MAP
kinase signal transduction in solid tumors. Genes Cancer.
4:342–359. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chen D, Liu Y, Yang H, Chen D, Zhang X,
Fermandes JC and Chen Y: Connexin 43 promotes ossification of the
posterior longitudinal ligament through activation of the ERK1/2
and p38 MAPK pathways. Cell Tissue Res. 363:765–773. 2016.
View Article : Google Scholar
|
